REGULATORY
Govt’s Draft Reform Timeline Prods MHLW to Discuss Use of “Economic Evaluations” in Reimbursement Decisions in FY2019
December 11, 2018
The Japanese government is expected to lean on health ministry panels to deliberate in FY2019 on the possible use of “economic evaluations” for making reimbursement decisions on new drugs and medical technologies, according to its draft reform timeline revealed on…

LATEST

December 11, 2018
Daiichi Sankyo said on December 10 that its investigational HER2-targeting antibody drug conjugate (ADC) DS-8201 (trastuzumab deruxtecan) delivered an overall response rate (ORR) of 44.2% in patients with HER2 low expressing metastatic breast cancer.According to Japan/US PI data presented at…
December 11, 2018
Chugai Pharmaceutical’s cancer drug Avastin (bevacizumab) was the best-selling drug in Japan for the fourth straight month in November with 10.2 billion yen on an NHI price basis, according to a monthly snapshot report released by market research firm Encise.Avastin…
December 11, 2018
Pfizer Japan launched a biosimilar version of the major rheumatoid arthritis (RA) drug Remicade (infliximab) on December 10, marking the company’s entry into the Japanese follow-on biologics market.The product, which joined the NHI price list in late November, is indicated…

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

NEWS CATEGORY

REGULATORY

BUSINESS

ORGANIZATION

ACADEMIA